Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIII) EBIT Margin (2020 - 2025)

Historic EBIT Margin for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to 12.81%.

  • P3 Health Partners' EBIT Margin rose 167400.0% to 12.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.64%, marking a year-over-year decrease of 9600.0%. This contributed to the annual value of 21.37% for FY2024, which is 81100.0% down from last year.
  • As of Q3 2025, P3 Health Partners' EBIT Margin stood at 12.81%, which was up 167400.0% from 9.59% recorded in Q2 2025.
  • In the past 5 years, P3 Health Partners' EBIT Margin ranged from a high of 6.39% in Q2 2023 and a low of 338.53% during Q2 2022
  • Its 5-year average for EBIT Margin is 45.0%, with a median of 17.96% in 2021.
  • Per our database at Business Quant, P3 Health Partners' EBIT Margin tumbled by -3205700bps in 2022 and then skyrocketed by 3321400bps in 2023.
  • Over the past 5 years, P3 Health Partners' EBIT Margin (Quarter) stood at 48.98% in 2021, then plummeted by -324bps to 207.79% in 2022, then skyrocketed by 91bps to 18.53% in 2023, then tumbled by -102bps to 37.36% in 2024, then skyrocketed by 66bps to 12.81% in 2025.
  • Its EBIT Margin stands at 12.81% for Q3 2025, versus 9.59% for Q2 2025 and 10.21% for Q1 2025.